KEY INSIGHTS
The North American newborn screening market is driven by the healthcare expenditure coupled with demand for quality healthcare affirms the adoption of new and different healthcare diseases which is positively supplementing growth in this region.

The market in this region is primarily driven by compensatory rules & regulations of newborn screening market in the United States along with the presence of many newborn screening centers & rising hearing disorders in newborn babies in Canada. The new born screening has its primary application in detection and diagnosis of diseases that mainly occur in infants and newborn babies

By the end of the forecast period of 2019-2027, the market is expected to grow at a CAGR of 13.73%.

Market Insights
The North American newborn screening market is segmented on the basis of technology, test types, and products. The growing incidence of fetal health-related abnormalities and government support towards new child healthcare management are factors that are significantly driving market growth.

The market in this region is driven by compensatory rules & regulations of the newborn screening market in United States along with the presence of many newborn screening centers & rising hearing disorders in newborn babies in Canada.

Competitive Insights
Leading players in this market include Sciex, Biotek Instruments Inc., Bio-Rad Laboratories Inc., Cardinal Health Inc., GE Healthcare Limited, Agilent Technologies Inc., Masimo Corporation, Natus Medical Incorporated, Medtronic PLC, Thermo Fisher Scientific Inc., Neogen Labs Pvt. Ltd., Perkinelmer Inc., Zentech S.A., Waters Corporation and Trivitron Healthcare.